Inhibition of Platelet Aggregation Caused by Estrogen Treatment in Patients with Carcinoma of the Prostate-Reference-Cited by-同舟云学术

Inhibition of Platelet Aggregation Caused by Estrogen Treatment in Patients with Carcinoma of the Prostate

Published:1975-07 Issue:1 Volume:114 Page:93-97
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Eisen M.¹,Napp H.E.¹,Vock R.¹

Affiliation:

1. From the Department of Urology, University of Mainz Medical School, Mainz, West Germany

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference39 articles.

1. The Veterans Administration Cooperative Urological Research Group: Treatment and survival of patients with cancer of the prostate;Surg., Gynec. & Obst.,1967

2. Uber die Hormonbehandlung des Prostatacarcinoms;Madsen;Urologe,1969

3. The Veterans Administration Cooperative Urological Research Group’s studies of cancer of the prostate;Byar;Cancer,1973

4. Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate;Blackard;Cancer,1970

5. The Veterans Administration Cooperative Urological Research Group: Estrogen treatment for cancer of the prostate: early results with 3 doses of diethylstilbestrol and placebo;Bailar;Cancer,1970

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: Evaluation of cardiovascular events in a randomized trial;Scandinavian Journal of Urology and Nephrology;2011-05-31

2. Estrogen receptor β2 and β5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion;Endocrine-Related Cancer;2010-09

3. Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5;Scandinavian Journal of Urology and Nephrology;2008-01-01

4. Parenteral Estrogen versus Combined Androgen Deprivation in the Treatment of Metastatic Prostatic Cancer - Scandinavian Prostatic Cancer Group (SPCG) Study No. 5;Scandinavian Journal of Urology and Nephrology;2002-01-01

5. Side effects of endocrine treatment and their mechanisms: Castration, antiandrogens, and estrogens;The Prostate;2000